Androgen Receptor Pathway As a Prognostic Indicator in Esophageal Adenocarcinoma

被引：0
|
作者：
Smith, Eric
Palethorpe, Helen M.
Ruszkiewicz, Andrew
Leach, Damien
Need, Eleanor
Drew, Paul
机构：
来源：
GASTROENTEROLOGY | 2015年 / 148卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1924
引用
收藏
页码：S356 / S356
页数：1
相关论文
共 50 条
  • [41] Lymphatic microvessel density as prognostic marker in esophageal adenocarcinoma
    Lindner, J. L.
    Silverman, J. F.
    Liu, Y. L.
    Tung, M.
    Sajjad, M. K.
    LABORATORY INVESTIGATION, 2007, 87 : 122A - 122A
  • [42] The prognostic significance of androgen receptor expression in gliomas
    Zhang, Chi
    Zhao, Nan
    Khan, Rubayat
    Hung, Ming-yang
    Wang, Shuo
    Wang, Tony J. C.
    Lin, Chi
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [43] Prognostic role of androgen receptor in bladder cancer
    Hartmann, Arndt
    Bertz, Simone
    Keck, Bastian
    Dyrskjot, Lars
    Orntoft, Torben
    Wullich, Bernd
    Hake, Roland
    Eidt, Sebastian
    Wirtz, Ralph
    CANCER RESEARCH, 2012, 72
  • [44] Histologic Subclassification of Esophageal Adenocarcinoma has Prognostic Significance
    Aggarwal, Ashna
    Gonzalez, Ivan
    Lu, Hsiang-Chih
    Maluf, Horacio
    Chatterjee, Deyali
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 610 - 611
  • [45] Prognostic impact of dose reduction in androgen receptor pathway inhibitors for castration-resistant prostate cancer
    Yamada, Shigetomo
    Shiota, Masaki
    Blas, Leandro
    Matsumoto, Takashi
    Kashiwagi, Eiji
    Takeuchi, Ario
    Inokuchi, Junichi
    Shiga, Ken-Ichiro
    Yokomizo, Akira
    Eto, Masatoshi
    PROSTATE INTERNATIONAL, 2022, 10 (01) : 50 - 55
  • [46] Evidence of androgen receptor expression in squamous and adenocarcinoma of the esophagus
    Tihan, T
    Harmon, JW
    Wan, XL
    Younes, Z
    Nass, P
    Duncan, KLK
    Duncan, MD
    ANTICANCER RESEARCH, 2001, 21 (4B) : 3107 - 3114
  • [47] Targeting the androgen receptor pathway in prostate cancer
    Chen, Yu
    Sawyers, Charles L.
    Scher, Howard I.
    CURRENT OPINION IN PHARMACOLOGY, 2008, 8 (04) : 440 - 448
  • [48] Validation of microRNA pathway polymorphisms in esophageal adenocarcinoma survival
    Faluyi, Olusola O.
    Eng, Lawson
    Qiu, Xin
    Che, Jiahua
    Zhang, Qihuang
    Cheng, Dangxiao
    Ying, Nanjiao
    Tse, Alvina
    Kuang, Qin
    Dodbiba, Lorin
    Renouf, Daniel J.
    Marsh, Sharon
    Savas, Sevtap
    Mackay, Helen J.
    Knox, Jennifer J.
    Darling, Gail E.
    Wong, Rebecca K. S.
    Xu, Wei
    Azad, Abul Kalam
    Liu, Geoffrey
    CANCER MEDICINE, 2017, 6 (02): : 361 - 373
  • [49] Androgen Receptor Pathway in Salivary Gland Cancer
    Ho, Alan L.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (36) : 4069 - +
  • [50] Basigin expression as a prognostic indicator in stage I pulmonary adenocarcinoma
    Matsumoto, Toshihide
    Nagashio, Ryo
    Ryuge, Shinichiro
    Igawa, Satoshi
    Kobayashi, Makoto
    Fukuda, Eriko
    Goshima, Naoki
    Ichinoe, Masaaki
    Jiang, Shi-Xu
    Satoh, Yukitoshi
    Masuda, Noriyuki
    Murakumo, Yoshiki
    Saegusa, Makoto
    Sato, Yuichi
    PATHOLOGY INTERNATIONAL, 2018, 68 (04) : 232 - 240
12345